On Friday, Shares of First Majestic Silver Corp. (NYSE:AG), gained 0.37% to $5.37.
First Majestic Silver, declared the unaudited interim merged financial results of the Company for the first quarter ended March 31, 2015.
FIRST QUARTER 2015 FINANCIAL HIGHLIGHTS
- Generated revenues of $54.6 million
- Mine operating earnings amounted to $5.0 million
- Net earnings after taxes amounted to a loss of $1.1 million or earnings per share of ($0.01)
- Adjusted earnings per share (a non-GAAP measure) of $0.00, after not taking into account non-cash and non-recurring items
- Cash flow per share (a non-GAAP measure) of $0.15
- All-in sustaining cost (“AISC”) was $13.88 per payable silver ounce
- Total cash cost, net of by-product credits, was $8.22 per payable silver ounce
- Average realized selling price for silver was $17.05 per ounce contrast to the quarterly COMEX average price of $16.70
- Cash and cash equivalents of $22.4 million held at the end of the quarter
- Subsequent to quarter end, the Company accomplished a CAD$30.0 million bought deal private placement, issuing 4,620,000 common shares at a price of CAD$6.50 per share.
First Majestic Silver Corp. engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver projects in Mexico. The company owns and operates five producing mines, counting the La Encantada silver mine in Coahuila State, the La Parrilla silver mine in Durango State, the Del Toro silver mine in Zacatecas State, the San Martin silver mine in Jalisco State, and the La Guitarra silver mine in Mexico State.
Shares of Mast Therapeutics, Inc. (NYSEMKT:MSTX), declined -2.09% to $0.52, during its last trading session.
Mast Therapeutics, stated financial results for the quarter ended March 31, 2015.
First Quarter 2015 Operating Results
The Company’s net loss for the first quarter of 2015 was $9.6 million, or $0.06 per share (basic and diluted), contrast to a net loss of $6.4 million, or $0.06 per share (basic and diluted), for the same period in 2014.
Research and development (R&D) expenses for the first quarter of 2015 were $6.0 million, an enhance of $1.7 million, or 41%, contrast to $4.3 million for the same period in 2014. The enhance was primarily due to enhances of $1.2 million in external clinical study fees and expenses and $0.4 million in external nonclinical study fees and expenses. Raised enrollment in the EPIC study was the primary driver of the enhance in R&D expenses.
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure.
At the end of Friday’s trade, Shares of Enphase Energy, Inc. (NASDAQ:ENPH), gained 4.46% to $10.54.
Enphase Energy, declared that Paul Nahi, president and CEO of Enphase Energy, is a finalist for the EY Entrepreneur Of The Year® 2015 Award in the Northern California Region. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Nahi was selected as a finalist by a panel of independent judges. Award winners will be declared at a special gala event on June 11 at the Fairmont, San Francisco.
Now in its 29th year, the program has expanded to recognize business leaders in more than 145 cities in more than 60 countries throughout the world.
Enphase Energy, Inc., together with its auxiliaries, designs, develops, and sells microinverter systems for the solar photovoltaic industry in the United States and internationally. The company’s microinverter systems comprises of an Enphase microinverter and related accessories that convert direct current power to grid-compliant alternating current power; an Envoy communications gateway device that collects and transmits performance information from each solar module to the company’s hosted data center; and an Enlighten Web-based software platform, which collects and processes this information to enable customers to monitor and manage their solar power systems.
Finally, Moody’s Corporation (NYSE:MCO), ended its last trade with 1.15% gain, and closed at $109.98, hitting its highest level.
Linda S. Huber, Executive Vice President and Chief Financial Officer of Moody’s Corporation, will speak at the Barclays Americas Select Franchise Conference on Wednesday, May 20, 2015 in London. Ms. Huber’s presentation will start at about 9:10 am BST and will be webcast live.
Moody’s Corporation provides credit ratings; and credit, capital markets, and economic related research, data, and analytical tools worldwide. The company operates through Moody’s Investors Service and Moody’s Analytics segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
